Amundi Biogen Inc. Transaction History

Amundi

$239 Billion
Q1 2024

A detailed history of Amundi transactions in Biogen Inc. stock. As of the latest transaction made, Amundi holds 985,802 shares of BIIB stock, worth $229 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

985,802

Previous 1,201,706 17.97%

Holding current value

$229 Million

Previous $311 Million 31.64%

% of portfolio

0.09%

Previous 0.14%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $45.8 Million - $57.8 Million	-215,904 Reduced 17.97%	985,802 $213 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $24.1 Million - $29 Million	108,182 Added 9.89%	1,201,706 $311 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $23.8 Million - $26.8 Million	-93,789 Reduced 7.9%	1,093,524 $281 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $168 Million - $194 Million	609,020 Added 105.31%	1,187,313 $338 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $61.7 Million - $70.3 Million	-240,340 Reduced 29.36%	578,293 $161 Million

Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $42.8 Million - $52.1 Million	169,737 Added 26.16%	818,633 $227 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $46.9 Million - $64.7 Million	241,061 Added 59.11%	648,896 $170 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $11.4 Million - $13.5 Million	60,579 Added 17.45%	407,835 $87.4 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $88.4 Million - $111 Million	-456,338 Reduced 56.79%	347,256 $73.5 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $11.5 Million - $14.8 Million	-51,409 Reduced 6.01%	803,594 $190 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $66.6 Million - $86.8 Million	235,305 Added 37.97%	855,003 $242 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $161 Million - $257 Million	619,698 New	619,698 $215 Million

Others Institutions Holding BIIB

# of Institutions

1,046

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account